Ghent University Academic Bibliography

Journal Article
A1
open access

Clinical outcomes of second relapsed and refractory first relapsed paediatric AML : a retrospective study within the NOPHO‐DB SHIP consortium

Tara White, Gertjan Kaspers, Jonas Abrahamsson, Nira Arad‐Cohen, Daniela Cianci, Jose Fernandez, Shau‐Yin Ha, Henrik Hasle, Barbara De Moerloose (UGent) , C. Michel Zwaan, et al.

(2022) BRITISH JOURNAL OF HAEMATOLOGY.

Add to list

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2021) PEDIATRIC RESEARCH. 89(7). p.1695-1705

Add to list

Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Anke Delie (UGent) , Anke Verlinden, Karolien Beel, Dries Deeren, Dominiek Mazure (UGent) , Frederic Baron, Dimitri Breems, Ann De Becker, Carlos Graux, Philippe Lewalle, et al.

(2021) ACTA CLINICA BELGICA. 76(6). p.500-508

Add to list

Journal Article
A1
open access

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

Bob Lowenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griskevicius, Lidwine W. Tick, Mojca Jongen-Lavrencic, et al.

(2021) BLOOD ADVANCES. 5(4). p.1110-1121

Add to list

Journal Article
A1
open access

RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia

Filip Matthijssens (UGent) , Nitesh D. Sharma, Monique Nysus, Christian K. Nickl, Huining Kang, Dominique R. Perez, Béatrice Lintermans (UGent) , Wouter Van Loocke (UGent) , Juliette Roels (UGent) , Sofie Peirs (UGent) , et al.

(2021) JOURNAL OF CLINICAL INVESTIGATION. 131(6).

Add to list

Journal Article
A1
open access

T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources

Sarah Bonte (UGent) , Stijn De Munter (UGent) , Glenn Goetgeluk (UGent) , Joline Ingels (UGent) , Melissa Pille (UGent) , Lore Billiet (UGent) , Tom Taghon (UGent) , Georges Leclercq (UGent) , Bart Vandekerckhove (UGent) and Tessa Kerre (UGent)

(2020) ONCOIMMUNOLOGY. 9(1).

Add to list

Sepsis and septic shock in patients with malignancies : a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique study

Virginie Lemiale, Stéphanie Pons, Adrien Mirouse, Jean-Jacques Tudesq, Yannick Hourmant, Djamel Mokart, Frédéric Pène, Achille Kouatchet, Julien Mayaux, Martine Nyunga, et al.

(2020) CRITICAL CARE MEDICINE. 48(6). p.822-829

Add to list

Journal Article
A1
open access

Absence of BCL-2 expression identifies a subgroup of AML with distinct phenotypic, molecular, and clinical characteristics

Inke De haes, Amélie Dendooven (UGent) , Marie Le Mercier, Pauline Puylaert, Katrien Vermeulen, Mark Kockx, Kathleen Deiteren, Marie-Berthe Maes, Zwi Berneman and Sebastien Anguille

(2020) JOURNAL OF CLINICAL MEDICINE. 9(10).

Add to list

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G. J. Ossenkoppele, D. A. Breems, G. Stuessi, Y. Van Norden, M. Bargetzi, B. J. Biemond, P. A von dem Borne, Y. Chalandon, J. Cloos, D. Deeren, et al.

(2020) LEUKEMIA. 34(7). p.1751-1759

Add to list

Journal Article
A1
open access

How to make an immune system and a foreign host quickly cohabit in peace? The challenge of acute graft-versus-host disease prevention after allogeneic hematopoietic cell transplantation

Benoit Vandenhove, Lorenzo Canti, Helene Schoemans, Yves Beguin, Frederic Baron, Carlos Graux, Tessa Kerre (UGent) and Sophie Servais

(2020) FRONTIERS IN IMMUNOLOGY. 11.

Academic Bibliography

Clinical outcomes of second relapsed and refractory first relapsed paediatric AML : a retrospective study within the NOPHO‐DB SHIP consortium

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia

T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources

Sepsis and septic shock in patients with malignancies : a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique study

Absence of BCL-2 expression identifies a subgroup of AML with distinct phenotypic, molecular, and clinical characteristics

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

How to make an immune system and a foreign host quickly cohabit in peace? The challenge of acute graft-versus-host disease prevention after allogeneic hematopoietic cell transplantation

Contents

Support

Contact